» Articles » PMID: 32248720

A Genome-wide CRISPR Screen Identifies Regulation Factors of the TLR3 Signalling Pathway

Overview
Journal Innate Immun
Publisher Sage Publications
Date 2020 Apr 7
PMID 32248720
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A subset of TLRs is specialised in the detection of incoming pathogens by sampling endosomes for nucleic acid contents. Among them, TLR3 senses the abnormal presence of double-stranded RNA in the endosomes and initiates a potent innate immune response via activation of NF-κB and IRF3. Nevertheless, mechanisms governing TLR3 regulation remain poorly defined. To identify new molecular players involved in the TLR3 pathway, we performed a genome-wide screen using CRISPR/Cas9 technology. We generated TLR3 reporter cells carrying a NF-κB-responsive promoter that controls GFP expression. Cells were next transduced with a single-guide RNA (sgRNA) library, subjected to sequential rounds of stimulation with poly(I:C) and sorting of the GFP-negative cells. Enrichments in sgRNA estimated by deep sequencing identified genes required for TLR3-induced activation of NF-κB. Among the hits, five genes known to be critically involved in the TLR3 pathway, including TLR3 itself and the chaperone UNC93B1, were identified by the screen, thus validating our strategy. We further studied the top 40 hits and focused on the transcription factor aryl hydrocarbon receptor (AhR). Depletion of AhR had a dual effect on the TLR3 response, abrogating IL-8 production and enhancing IP-10 release. Moreover, in primary human macrophages exposed to poly(I:C), AhR activation enhanced IL-8 and diminished IP-10 release. Overall, these results reveal AhR plays a role in the TLR3 cellular innate immune response.

Citing Articles

Protocol for iterative enrichment of integrated sgRNAs via derivative CRISPR-Cas9 libraries from genomic DNA of sorted fixed cells.

Ordonez A, Ron D, Harding H STAR Protoc. 2024; 5(4):103493.

PMID: 39661507 PMC: 11697544. DOI: 10.1016/j.xpro.2024.103493.


A new cell line based coculture system for skin sensitisation testing in one single assay using T cells, aryl hydrocarbon receptor knockout, and co-inhibitory blockage.

Sonnenburg A, Stahlmann R, Kreutz R, Peiser M Arch Toxicol. 2023; 97(6):1677-1689.

PMID: 37147507 PMC: 10182954. DOI: 10.1007/s00204-023-03506-3.


Tumor immunology CRISPR screening: present, past, and future.

Dong M, Tang K, Zhou X, Zhou J, Chen S Trends Cancer. 2021; 8(3):210-225.

PMID: 34920978 PMC: 8854335. DOI: 10.1016/j.trecan.2021.11.009.


What sequencing technologies can teach us about innate immunity.

Salih M, Carpenter S Immunol Rev. 2021; 305(1):9-28.

PMID: 34747035 PMC: 8865538. DOI: 10.1111/imr.13033.

References
1.
Lee C, Carette J, Brummelkamp T, Ploegh H . A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κB. PLoS One. 2013; 8(7):e70339. PMC: 3704534. DOI: 10.1371/journal.pone.0070339. View

2.
Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

3.
Larigot L, Juricek L, Dairou J, Coumoul X . AhR signaling pathways and regulatory functions. Biochim Open. 2018; 7:1-9. PMC: 6039966. DOI: 10.1016/j.biopen.2018.05.001. View

4.
Itoh H, Tatematsu M, Watanabe A, Iwano K, Funami K, Seya T . UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS One. 2011; 6(12):e28500. PMC: 3229609. DOI: 10.1371/journal.pone.0028500. View

5.
Burr S, Costa A, Grice G, Timms R, Lobb I, Freisinger P . Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. Cell Metab. 2016; 24(5):740-752. PMC: 5106373. DOI: 10.1016/j.cmet.2016.09.015. View